« Back to Record
Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., Mariavelle, E., O'Grady, T. M., Hassoun, Z. E. O., Claes, M., Dubois, L., Lee, K. A. W., Kruys, V., Gueydan, C., Durand, J., Hervouet, E., Geyer, F. F., Banito, A., Imle, R., Mao, L., Jayavelu, A. A., Grünewald, T. T., Cidre-Aranaz, F., Twizere, J.-C., & Dequiedt, F. (2025). Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nature communications, 16(1), 6537. doi:10.1038/s41467-025-61725-x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/392931



